Cardiovascular Research

An Urgent Call for Studies That Address the Cardiovascular Consequences of Legalization of Marijuana.

Authors: Shereif H Rezkalla|||Robert A Kloner

Affiliations: + Expand

Abstract

In about a decade, half of the United States has legalized marijuana for recreational use. The drug has been associated with acute myocardial infarction, acute stroke, congestive heart failure, and various cardiac arrythmias. Data have shown that legalization of the drug led to an increase of its use as well as an increase in tetra hydro cannabinoid positive tests in patients admitted to emergency departments. In Colorado, one of the earlier states to implement legalization, there was an increase in traffic accidents, suicide rates, and even total mortality. However, there is a paucity of data on the effect of marijuana legalization on various cardiovascular events. It is prudent to have well-designed studies with enough power to provide consumers and health care providers the information they need to decide whether the risks of marijuana, especially on the cardiovascular front, are worth the "high" or potential benefits that have been described for other medical conditions.

---

Reference List

Rezkalla S, Kloner RA. Recreational marijuana use: is it safe for your patient? J Am Heart Assoc. 2014;3(2):e000904. doi: 10.1161/JAHA.114.000904.|||Lamarine RJ. Marijuana: modern medical chimaera. J Drug Educ. 2012;42(1):1–11. doi: 10.2190/DE.42.1.a.|||Page RL 2nd, Allen LA, Kloner RA, Carriker CR, Martel C, Morris AA, Piano MR. et al. Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2020;142(10):e131–e152. doi: 10.1161/CIR.0000000000000883.|||Beaconsfield P, Ginsburg J, Rainsbury R. Marihuana smoking. Cardiovascular effects in man and possible mechanisms. N Engl J Med. 1972;287(5):209–212. doi: 10.1056/NEJM197208032870501.|||Rezkalla SH, Sharma P, Kloner RA. Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med. 2003;42(3):365–369. doi: 10.1016/s0196-0644(03)00426-8.|||Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol. 2014;113(1):187–190. doi: 10.1016/j.amjcard.2013.09.042.|||Rezkalla S, Stankowski R, Kloner RA. Cardiovascular effects of marijuana. J Cardiovasc Pharmacol Ther. 2016;21(5):452–455. doi: 10.1177/1074248415627874.|||Rezkalla S, Kloner RA. Cardiovascular effects of marijuana. Trends Cardiovasc Med. 2019;29(7):403–407. doi: 10.1016/j.tcm.2018.11.004.|||Sandhyavenu H, Patel HP, Patel RH, Desai R, Patel AA, Patel BA, Patel J. et al. Rising trend of acute myocardial infarction among young cannabis users: A 10-year nationwide gender and race stratified analysis. Int J Cardiol Cardiovasc Risk Prev. 2023;16:200167. doi: 10.1016/j.ijcrp.2022.200167.|||Shah S, Patel S, Paulraj S, Chaudhuri D. Association of marijuana use and cardiovascular disease: a behavioral risk factor surveillance system data analysis of 133,706 US adults. Am J Med. 2021;134(5):614–620.e611. doi: 10.1016/j.amjmed.2020.10.019.|||Phillips KT, Pedula KL, Choi NG, Tawara KK, Simiola V, Satre DD, Owen-Smith A. et al. Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai'i who use cannabis: A matched cohort study. Drug Alcohol Depend. 2022;234:109387. doi: 10.1016/j.drugalcdep.2022.109387.|||Rumalla K, Reddy AY, Mittal MK. Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States. J Neurol Sci. 2016;364:191–196. doi: 10.1016/j.jns.2016.01.066.|||Desai R, Fong HK, Shah K, Kaur VP, Savani S, Gangani K, Damarlapally N. et al. Rising trends in hospitalizations for cardiovascular events among young cannabis users (18-39 Years) without other substance abuse. Medicina (Kaunas) 2019;55(8):438. doi: 10.3390/medicina55080438.|||Kalla A, Krishnamoorthy PM, Gopalakrishnan A, Figueredo VM. Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample. J Cardiovasc Med (Hagerstown) 2018;19(9):480–484. doi: 10.2459/JCM.0000000000000681.|||Dhillon BK, Sombans S, Ramphul K. et al. Abstract P580: cannabis use among young females of ages 15 to 35 admitted for heart failure in the United States. Circulation. 2023;147:AP580. doi: 10.1161/circ.147.suppl_1-P580.|||Sun Y, Liu B, Wallace RB, Bao W. Association of cannabis use with all-cause and cause-specific mortality among younger- and middle-aged U.S. adults. Am J Prev Med. 2020;59(6):873–879. doi: 10.1016/j.amepre.2020.07.010.|||Abouk R, Adams S. Examining the relationship between medical cannabis laws and cardiovascular deaths in the US. Int J Drug Policy. 2018;53:1–7. doi: 10.1016/j.drugpo.2017.11.022.|||Parikh K, Patel M, Bansal T, Raco J, Gupta S, Jain R, Jain R. Cannabis and the heart: unchartered territory. Future Cardiol. 2022;18(11):883–890. doi: 10.2217/fca-2022-0018.|||Rocky Mountain High Intensity Drug Trafficking Area Program. The legalization of marijuana in Colorado: the impact: volume 8, September 2021. Mo Med. 2021;118(6):534–535.|||Farrelly KN, Wardell JD, Marsden E, Scarfe ML, Najdzionek P, Turna J, MacKillop J. The impact of recreational cannabis legalization on cannabis use and associated outcomes: a systematic review. Subst Abuse. 2023;17:11782218231172054. doi: 10.1177/11782218231172054.|||Tolan NV, Krasowski MD, Mathias PC, Wiencek JR, Babic N, Chai PR, Chambliss AB. et al. Cannabis positivity rates in 17 emergency departments across the United States with varying degrees of marijuana legalization. Clin Toxicol (Phila) 2023;61(4):248–259. doi: 10.1080/15563650.2023.2177552.|||Jeffers AM, Lightwood J, Keyhani S. Abstract P250: the impact of recreational cannabis legalization on all-cause hospitalizations and acute cardiovascular event hospitalizations in Colorado. Circulation. 2020;141(Suppl_1)|||Tolan NV, Terebo T, Chai PR, Erickson TB, Hayes BD, Uljon SN, Petrides AK. et al. Impact of marijuana legalization on cannabis-related visits to the emergency department. Clin Toxicol (Phila) 2022;60(5):585–595. doi: 10.1080/15563650.2021.2012576.|||Masonbrink AR, Richardson T, Hall M, Catley D, Wilson K. Trends in adolescent cannabis-related hospitalizations by state legalization laws, 2008-2019. J Adolesc Health. 2021;69(6):999–1005. doi: 10.1016/j.jadohealth.2021.07.028.|||Hall W, Lynskey M. Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction. 2016;111(10):1764–1773. doi: 10.1111/add.13428.